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The validation of breast cancer risk models is important, and that
by MacInnis et al (2013) of the BOADICEA model, which is based
solely on family history, is very welcome. A recent development
has been the identification of 67 breast cancer risk SNPs
(Michailidou et al, 2013), whose main use will be together as a
panel to identify women at increased risk of breast cancer.
We investigated how a polygenic SNP score based on these SNPs
would compare with classical risk factors including family history,
and how much information it might add to risk assessment.
Our analysis was based on simulated SNP scores from 100 000
women with population allele frequencies for the 67 SNPs, and
treating them as independent so that a combined risk score can be
obtained by multiplying their relative risks; and the Tyrer-Cuzick
(TC) risk model (Tyrer et al, 2004) predictions from the first 10 000
women enrolled to the PROCAS study (predicting risk of breast
cancer at screening) in Manchester, UK (Evans et al, 2012). The TC
model is based on classical phenotypic factors including age, family
history, age at menopause and menarche, and parity. The outcome
measure was the 10-year relative risk of developing breast cancer.
Histograms are shown in Figure 1 for the TC model, the SNP
score using 18 genes previously published (Turnbull et al, 2010)
but with risks updated from the COGS analysis in Michailidou
et al (2013), the full set of 67 SNPs, and a combined TCþ SNP67
distribution assuming independence. Initial evaluations have
shown the TC and SNP18 scores appear to be independent
(Evans et al, 2012).
Of particular interest is the 48% 10-year risk group, where
NICE (2013) guidelines in the UK advise offering the preventive
use of tamoxifen. The SNP score was less able to identify women at
high risk than the TC model (0.02% for SNP18, 0.37% for SNP67
and 0.77% for the TC model). However, adding SNP67 to TC gave
a substantial increment to 2.85%, and similar effects were seen in
the 5–8% 10-year risk group (1.72%, 4.28%, 6.64% and 8.17%,
respectively), which is equivalent to the NICE moderate-risk
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Figure 1. Predicted 10-year relative risk and corresponding absolute
10-year risk for a woman aged 50 using classical factors (TC), 18 SNPs
from Turnbull et al (2010), the 67 COGS SNPs (SNP67) and combined
(TCþSNP67). The phenotypic markers are from 10000 women of
routine screening age (46–70 years) in the UK.
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category where tamoxifen may be ‘considered’. It is also noticeable
that the SNPs identified more low-risk women than the TC model,
which mainly uses uncommon high-risk phenotypes.
These data suggest that although the spread towards high-risk
currently achieved by SNP67 is not as large as that obtained from
classical phenotypic markers, SNPs may add substantially to classic
factors when used together.
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